Tumorigenesis of murine erythroleukemia cell line transfected with exogenous p53 gene

Clinical Hemorheology and Microcirculation

Volumn 30, Issue 2, 2004, Pages 117-126

  Sun, Dagong ^a   Wang, Jinhua ^a   Yao, Weijuan ^a   Gu, Li ^a   Wen, Zongyao ^a,c   Shu, Chien ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

Gene transfection; Murine erythroleukemia cells; p53 gene; Tumorigenesis

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION; BLOOD; BLOOD RHEOLOGY; BONE MARROW; CANCER CELL CULTURE; CELL DENSITY; CELL MIGRATION; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; ERYTHROLEUKEMIA; ERYTHROLEUKEMIA CELL; GENETIC TRANSFECTION; HEMATOCRIT; HISTOPATHOLOGY; IN VIVO STUDY; LEUKEMOGENESIS; LEUKOCYTE COUNT; LIVER; MALE; MEASUREMENT; MICROPIPETTE; MOUSE; MOUSE STRAIN; NONHUMAN; RETICULOCYTE COUNT; SPLEEN; THROMBOCYTE COUNT; WILD TYPE; YOUNG MODULUS;

ANIMALS; BLOOD CELL COUNT; BONE MARROW; CELL LINE, TUMOR; ELASTICITY; ERYTHROCYTE DEFORMABILITY; GENES, P53; HEMATOCRIT; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LIVER; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ORGAN SIZE; REMISSION, SPONTANEOUS; SPLEEN; TRANSFECTION; VIRULENCE;

EID: 1642447867     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Z.Z. Wu, G. Zhang, M. Long, H.B. Wang, G.B. Song and S.X. Cai, Comparison of the viscoelastic properties of normal hepatocytes and hepatocellular carcinoma cells under cytoskeletal perturbation, Biorheology 37 (2000), 279-290.
2. Y.J. Geng, Molecular signal transduction in vascular cell apoptosis, Cell Res. 11 (2001), 253-264.
3. WAF1 in NIH 3T3 cells malignantly transformed by mot-2, Cell Res. 11 (2001), 55-60.
4. H. Zhao and Y.H. Xu, mad-overexpression down regulates the malignant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells, Cell Res. 9 (1999), 51-60.
5. B. Vogelstein, D. Lane and A.J. Levine, Surfing the p53 network, Nature 408 (2000), 307-310.
6. G.A. Beaudry, A.H. Bertelsen and M.I. Sherman, Therapeutic targeting of the p53 tumor suppressor gene, Curr. Opin. Biotech. 7 (1996), 592-600.
7. E.H. Chang, K.F. Pirollo and K.B. Bouker, Tp53 gene therapy: a key to modulating resistance to anticancer therapies?, Mol. Med. Today 6 (2000), 358-364.
8. D.G. Munroe, J.W Peacock and S. Benchimol, Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles, Mol. Cel. Biol. 10 (1990), 3307-3313.
9. C.T. Quang, M. Pironin, M. von-Lindern, H. Beug and J. Ghysdael, Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors, Oncogene 11 (1995), 1229-1239.
10. O.K. Baskurt, D. Gelmont, H.J. Meiselman, Red blood cell deformability in sepsis, Am. J. Respir. Crit. Care Med. 157 (1998), 421-427.
11. O.K. Baskurt and F. Mat, Importance of measurement temperature in detecting the alterations of red blood cell aggregation and deformability studied by ektacytometry: a study on experimental sepsis in rats, Clin. Hemorheol. Microcirc. 23 (2000), 43-49.
12. W.J. Yao, L. Gu, D.G. Sun, W.B. Ka, Z.Y. Wen and S. Chien, Wild type p53 gene causes reorganization of cytoskeleton and therefore the impaired eformability and difficult migration of murine erythroleukemia cells, Cell Motility and the Cytoskeleton 56 (2003), 1-12.
13. S.J. Wang, H.P. Zhou and T.A. Xia, Diagnosis and Therapy Handbook, The Union Press of Beijing Medical University and China Union Medical University, 1995, pp. 5-9.
14. International Committee for Standardization in Haematology. Expert panel on blood rheology. Guidelines for measurement blood viscosity and erythrocyte deformability, Clin. Hemorheol. 6 (1986), 439-453.
15. Z.Y. Wen, Z.L. Tao, S. Cao and Y.H. Zhao, Can we use PBS as an alternative to dextran in ektacytometric measurement?, Clin. Hemorheol. 11 (1991), 459-464.
16. C.J. Wachter, P.L. Frattini and B.P. Griffith, Erythrocyte deformability in patients during left verntricular assistance, Clin. Hemorheol. 11 (1991), 325-337.
17. W.J. Yao, Z.Y. Wen, Z.Y. Yan, D.G. Sun, W.B. Ka, L.D. Xie and S. Chien, Low viscosity ektacytometery and its validation tested by flow chamber, J. Biomechan. 34 (2001), 1501-1509.
18. G.W. Schmid-Schönbein, K.P. Sung, H. Tözeren, R. Skalak and S. Chien, Passive mechanical properties of human leukocytes, Biophys. J. 36 (1981), 243-256.
19. Z.Y. Wen, Z.Y. Yan, T. Gao, H.F. Dou, Lu J.F., D.G. Sun and Z.H. Lu, A study of effects of WGA and ConA on RBC membrane receptors using a new ektacytometric method, Clin. Hemorheol. Microcirc. 17 (1997), 467-478.
20. Z.Y. Wen, Z.L. Tao, W.Y. Ma and D.G. Sun, The influence of surface charge of RBC membrane upon its orientation in a shear flow field of low viscosity, Clin. Hemorheol. 14 (1994), 279-283.
21. W.J. Yao, K. Chen, X.J. Wang, L.D. Xie, Z.Y. Wen, Z.Y. Yan and S. Chien, Influence of TRAIL gene on biomechanical properties of the human leukemic cell line Jurkat, J. Biomechan. 35 (2002), 659-1663.
22. M. Miyazama, J. Nishio, K. Wehrly and B. Chesebro, Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia, J. Immunol. 148 (1992), 644-647.